Gutierrez, Khent Andrey C.

HRN: 19-63-18  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/18/2026
01/25/2026
IV
1.2G
Q6H
PCAP C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: